Sol Gel Techn Is 10 Stock EBITDA

4SG Stock  EUR 0.49  0.02  4.26%   
SOL GEL TECHN IS 10 fundamentals help investors to digest information that contributes to SOL GEL's financial success or failures. It also enables traders to predict the movement of SOL Stock. The fundamental analysis module provides a way to measure SOL GEL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SOL GEL stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

SOL GEL TECHN IS 10 Company EBITDA Analysis

SOL GEL's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current SOL GEL EBITDA

    
  4.75 M  
Most of SOL GEL's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SOL GEL TECHN IS 10 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, SOL GEL TECHN IS 10 reported earnings before interest,tax, depreciation and amortization of 4.75 M. This is 99.46% lower than that of the Healthcare sector and 95.26% lower than that of the Biotechnology industry. The ebitda for all Germany stocks is 99.88% higher than that of the company.

SOL EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SOL GEL's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SOL GEL could also be used in its relative valuation, which is a method of valuing SOL GEL by comparing valuation metrics of similar companies.
SOL GEL is currently under evaluation in ebitda category among its peers.

SOL Fundamentals

About SOL GEL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze SOL GEL TECHN IS 10's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SOL GEL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SOL GEL TECHN IS 10 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in SOL Stock

SOL GEL financial ratios help investors to determine whether SOL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SOL with respect to the benefits of owning SOL GEL security.